If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Baqsimi ® (glucagon) nasal powder
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
What is Baqsimi™ (glucagon) nasal powder indicated for?
Glucagon nasal powder is indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 and above.
Baqsimi is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 and above.1
Enclosed Prescribing Information
1Baqsimi [package insert]. Indianapolis, IN: Eli Lilly and Company; 2020.
Date of Last Review: October 25, 2021